Your Article Summary
See Latest ArticlesSymptom Variability During Repeated Measurement Among Hospice Patients With Advanced Cancer
American Journal of Hospice and Palliative Medicine, 07/02/09
Lasheen W et al. - Symptom studies in advanced disease while difficult to conduct yield valuable information, symptom relationships changed daily; strict timing of data collection is crucial for data analysis, symptom monitoring following admission is an overlooked measure of risk assessment, symptom prevalence studies alone for treatment follow-up may be misleading, depression is an important predictor of symptoms and need to be more aggressively assessed and treated, demographic characteristics may help identify symptom patterns and better direct treatment, VRS rather than VAS was more reliable for assessing symptoms in hospice cancer patients.
Related Articles
Obesity linked to specific cancers
Internet Source, 11/05/09
Relevance Score: 97%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 97%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 97%
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 97%
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 97%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/17/09